The Food and Drug Administration has issued a warning to doctors about the risk of complications associated with the transvaginal mesh patch. These surgical mesh patches can be used during surgery for the treatment of stress urinary incontinence (SUI) and pelvic organ prolapse (POP).
According to the FDA’s warning, the agency received more than 1,000 reports of complications from the transvaginal mesh patch over the last three years. Side effects that have been associated with transvaginal mesh include severe pain, vaginal mesh erosion, infection, urinary problems, pain during sex or recurrent prolapse.
In some cases, patients who have experienced problems with the transvaginal mesh patch have been forced to undergo repeat surgeries to remove or repair problems with the patch. Despite the FDA’s warning, the agency has not announced plans to issue a transvaginal mesh recall.